These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29258902)

  • 1. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
    Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.
    Zhang Q; Ubago J; Li L; Guo H; Liu Y; Qiang W; Kim JJ; Kong B; Wei JJ
    Cancer; 2014 Oct; 120(20):3165-77. PubMed ID: 24986214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas.
    Zhai YL; Kobayashi Y; Mori A; Orii A; Nikaido T; Konishi I; Fujii S
    Int J Gynecol Pathol; 1999 Jan; 18(1):20-8. PubMed ID: 9891238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus.
    Zhai YL; Nikaido T; Shiozawa T; Orii A; Fujii S
    Int J Cancer; 1999 Jun; 84(3):244-50. PubMed ID: 10371341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
    Zhu XQ; Shi YF; Cheng XD; Wu YZ
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein overexpression in smooth muscle tumors of the uterus.
    Niemann TH; Raab SS; Lenel JC; Rodgers JR; Robinson RA
    Hum Pathol; 1995 Apr; 26(4):375-9. PubMed ID: 7705814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.
    Paal E; Miettinen M
    Am J Surg Pathol; 2001 Nov; 25(11):1355-63. PubMed ID: 11684951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
    Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
    Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smooth muscle neoplasms of the uterus--a 51 cases study].
    Wang M; Xu Y; Zhang T
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):263-5. PubMed ID: 9388867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.
    Miettinen M; Sarlomo-Rikala M; Sobin LH; Lasota J
    Am J Surg Pathol; 2000 Feb; 24(2):211-22. PubMed ID: 10680889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.
    Gökaslan H; Türkeri L; Kavak ZN; Eren F; Sişmanoğlu A; Ilvan S; Durmuşoğlu F
    Gynecol Obstet Invest; 2005; 59(1):36-40. PubMed ID: 15377824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
    Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
    Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.